This document is a judgment from the European Court of Human Rights regarding the case of Babar Ahmad and Others v. The United Kingdom, concerning the extradition of six terrorism suspects (including Abu Hamza) to the United States. The applicants argued that extradition would violate Article 3 of the European Convention on Human Rights due to the risk of solitary confinement at ADX Florence and the possibility of grossly disproportionate life sentences. The Court unanimously ruled that extradition would not violate Article 3, finding that conditions at ADX Florence and the potential sentences did not amount to inhuman or degrading treatment.
This document is a page from a court transcript dated August 10, 2022, detailing the direct examination of a witness named Loftus. In the testimony, Loftus describes their professional affiliations with several major psychological organizations. They highlight their past leadership roles, including serving as president for the Association for Psychological Science, the Western Psychological Association (twice), and divisions of the American Psychological Association.
This document is a page from a court transcript dated August 10, 2022, from the direct examination of a witness named Loftus. Loftus describes their professional affiliations with several major psychological organizations, including the Association for Psychological Science, the Western Psychological Association, and the American Psychological Association, highlighting past presidencies and other leadership roles within these groups.
This document is a page from a professional resume or curriculum vitae for Stephen Gillers, filed as part of a court case. It details his public lectures, participation in PBS series on ethics and the Constitution, and extensive legal and public service activities. Key activities include holding leadership and member roles in various American Bar Association commissions and being retained by the New Jersey Supreme Court to analyze lawyer disciplinary systems.
This document is page 9 of 239 from a legal filing in case 1:20-cr-00330-PAE, filed on April 16, 2021. It is a table of authorities, listing numerous legal case citations alphabetically from 'Miller v. Pate' to 'SEC v. TheStreet.com'. Each entry includes the case name, its legal reporter citation, and the page numbers where it is referenced within the main document.
This document is Page 3 of a legal filing entitled 'Table of Authorities' from Case 1:20-cr-00330-AJN (United States v. Ghislaine Maxwell), filed on June 18, 2020. It lists numerous legal precedents cited in the filing, primarily 'United States v. [Defendant]' cases. Notably, the list includes two citations for 'United States v. Epstein' (one from 2001 in E.D. Pa. and one from 2019 in S.D.N.Y.) and one for 'United States v. Madoff'.
This document is a handwritten note, possibly a passenger list for a Boeing 727 aircraft. It contains a list of names, several of which are paired together, and mentions "oregon", a time of "Friday 5:30pm", and the days "Thu + Mon". The note is dated October 5, 2017, and appears to be related to coordinating travel or a meeting for the individuals listed.
This document appears to be a news article or report excerpt bearing a House Oversight Committee Bates stamp (HOUSE_OVERSIGHT_019426). It details the technical challenges, anticipated glitches, and testing issues surrounding the rollout of the Affordable Care Act (Obamacare) health insurance exchanges in various states (CA, OR, NV, DC) and at the federal level. Despite the user prompt, the document contains absolutely no text related to Jeffrey Epstein, Ghislaine Maxwell, or their associates; it is entirely focused on healthcare policy implementation circa 2013.
This document appears to be a page from a legal brief or memorandum submitted by attorney David Schoen to the House Oversight Committee (indicated by the Bates stamp). The text discusses legal precedents and statutes (specifically the CVRA and state laws in Utah, Oregon, South Dakota, and Texas) regarding a prosecutor's ethical obligation to inform the court of a victim's request to be heard during plea bargain proceedings. This is likely part of an argument regarding the violation of victims' rights in the context of the Jeffrey Epstein non-prosecution agreement.
This document appears to be a page from a news article or report discussing scientific advancements in human cloning and embryonic stem cell research conducted by a team at OHSU (Oregon Health & Science University). It details the methodology used (specifically the use of caffeine, dubbed 'the Starbucks effect'), the ethical debates surrounding egg donation and compensation, and the legal landscape in the United States regarding cloning. While Jeffrey Epstein is not mentioned by name on this page, the content aligns with his known interests in transhumanism, genetic engineering, and scientific funding, and the document bears a House Oversight footer.
This document is a compilation of three media summaries/articles from May and June 2007 regarding GTX Corporation (Global Trek Xploration Corp.) and its CEO, Patrick Bertagna. The articles detail the company's development of GPS-embedded footwear (Xplorer Smart Shoes) designed to track children, Alzheimer's patients, and others. The document is stamped as evidence from the House Oversight Committee (HOUSE_OVERSIGHT_018146).
This document is a compilation of three news excerpts from 2007 regarding GTX Corporation (Global Trek Xploration Corp.) and its CEO Patrick Bertagna. The articles discuss the development of GPS-embedded footwear (Xplorer Smart Shoes) designed to track children, Alzheimer's patients, and others, citing the Elizabeth Smart abduction as inspiration. The document bears a House Oversight footer (HOUSE_OVERSIGHT_032095).
This page is an excerpt from an Ackrell Capital 'Cannabis Investment Report' dated December 2017. The text details the regulatory frameworks, licensing requirements, and taxation structures for recreational cannabis in various US states (WA, CA, MA, NV, OR, CO). While the document bears a 'HOUSE_OVERSIGHT' bates stamp, suggesting it was part of a document production for a congressional investigation (possibly involving financial records), the text on this specific page contains no mention of Jeffrey Epstein, his associates, or his specific financial transactions.
This document is page 65 (Chapter IV) of a 2017 report by Ackrell Capital regarding the U.S. legal landscape for cannabis. It details the history of CBD-specific legislation (Carly's Law, etc.) and the timeline of recreational legalization across various states between 2012 and 2016. While the document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was part of a congressional investigation document production, the content is strictly an industry analysis of cannabis laws and contains no direct textual references to Jeffrey Epstein or his associates.
This document is page 64 of a 'Cannabis Investment Report' dated December 2017, authored by Ackrell Capital. It provides a detailed overview of Medical Cannabis Laws in the United States, discussing the history of legalization starting with California in 1996, the legal distinction between 'prescribing' and 'recommending' under the CSA, qualifying medical conditions (listing over 50), and state-specific restrictions such as Pennsylvania's 2016 law. The document contains a Bates stamp 'HOUSE_OVERSIGHT_024700', indicating it was part of a document production to the House Oversight Committee, likely within a larger tranche of financial or investment records.
This document is a page from an Ackrell Capital report (Chapter IV: U.S. Legal Landscape) featuring a map and list of U.S. state cannabis laws as of January 2018. It categorizes states by Recreational Law, Medical Cannabis Law, CBD/Limited Law, or No Law. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production to Congress (potentially related to financial investigations involving Epstein or related banks), the content itself is purely market research regarding the cannabis industry and contains no specific mention of Jeffrey Epstein or his associates.
This page from an Ackrell Capital report details the 'Infused Products' segment of the cannabis industry, breaking down sales by category for Q3 2017 in Colorado, Oregon, and Washington. It specifically highlights 'Edibles,' explaining their manufacturing, consumption methods, metabolic processes, and distinct physiological effects compared to inhalation.
This document is page 35 of a 2017 industry report by Ackrell Capital regarding the cannabis industry. It details the economics and logistics of cannabis cultivation, comparing indoor vs. outdoor/greenhouse methods, and discusses legal challenges regarding interstate commerce. The document bears a 'HOUSE_OVERSIGHT_024671' stamp, indicating it was part of a document production for a Congressional investigation.
This page from an Ackrell Capital report discusses the potential first FDA approval of a cannabis-derived pharmaceutical (Epidiolex) in 2018 and its implications. It also analyzes the commoditization of cannabis flower, noting a downward pricing trend in legalized states like Colorado, Oregon, and Washington, illustrated by a graph of prices from 2016 to 2017.
This document appears to be page 39 of a manuscript or psychological report contained within House Oversight materials (Bates stamp HOUSE_OVERSIGHT_013539). The text analyzes the psychological profiles of NFL players, contrasting the 'structure loving' nature of offensive players with the 'rebellious' nature of defensive players. It specifically cites the San Diego Chargers' use of these findings to justify drafting quarterback Dan Fouts, despite concerns about his physical toughness during his college years in Oregon.
This document is page 144 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It contains company profiles for four businesses in the cannabis industry: Confident Cannabis, Cultivation Technologies, Cura Cannabis Solutions, and CW Analytical. The document bears a House Oversight Bates stamp number 024780.
This document is page 104 of a December 2017 Cannabis Investment Report authored by Ackrell Capital, LLC. It analyzes market trends, including the medical efficacy of cannabis, the increase in recreational legalization (citing Uruguay, Canada, and US states like Colorado and California), product innovation, and pricing dynamics between legal and illegal markets. The document bears a 'HOUSE_OVERSIGHT_024740' stamp, indicating it was part of a document production for a Congressional investigation, though the text itself contains no direct references to Jeffrey Epstein or specific individuals.
Page 2 of 4 of an LA Times interview with Alan Trounson (dated May 29, 2013) discussing the state of stem cell research in California. Trounson outlines plans to request $70 million from the CIRM board to establish a network of clinics and compares California's collaborative research environment (funded by Proposition 71's $3 billion) to the competitive environments of Harvard and Australia. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional document production.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity